Stock screener

OTLK

Conviction 48HealthcareScan · Mon, Aug 10, 2026
OTLK$1.15+12.75%
ResistanceSupportVol 14Insider buy
63 bars
6
3
Vol MA14 16.96M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest -50.00%· 3 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Outlook Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.outlooktherapeutics.com ↗
Price1.15
Change+12.75%
Gap-1.47%
Rel volume0.61×
Avg volume14.56M
Avg $ vol17.41M
SMA 201.20
SMA 501.27
SMA 2000.9226
Price vs 50-9.45%
Price vs 200+24.65%
MA stackmixed
50/200 cross—
Supertrenddown · 1.48
RSI (14)49
MACD hist-0.02
MACD cross—
Stoch %K / %D35 / 24
ADX (14)19
+DI / −DI28 / 20
RSI divergence—
MACD divergence—
ATR %+14.77%
ADR %14.53%
52w high2.97
52w low0.1981
From 52w high-61.28%
Above 52w low+480.51%
New 52w highNo
SqueezeOff
Bollinger width79.73%
%B0.45
Donchian pos33.00%
Donchian high1.82
Donchian low0.8200
AVWAP (52w high)0.9182
vs AVWAP high+25.24%
AVWAP (52w low)0.8285
vs AVWAP low+38.81%
OBV trendFlat
Chaikin MF (20)-0.14
Today vs 20d0.61×
Avg vol (14d)16.96M
Avg vol (20d)14.56M
Avg $ vol (20d)17.41M
Market cap138.99M
RS 3m (vs SPY)+367.18%
RS 6m (vs SPY)+147.42%
RS line new highNo
Trend template4/8
Technical rank64.6
1 week+25.96%
1 month-26.75%
3 months+419.66%
6 months+167.82%
1 year-37.50%
YTD+74.24%
P/E-2.23
P/B-4.79
P/S98.33
P/FCF-2.66
EPS-1.79
Div yield—
ROE215.30%
ROA-285.14%
Debt/Eq-33.35
Current0.54
EV/EBITDA-16.43
Gross margin4.05%
Net margin—
Rev growth—
EPS growth17.17%
Price target5.20
Target upside352.17%
Analyst ratingBuy
Institutional7.27%
Ent. value1.1B
Revenue1.51M
Net income-4.45M
Gross profit-21.89K
Free cash flow-52.27M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out140.05M
Employees17
ListedFri, May 13, 2016
Free float83M
Float %99.9%
Short interest11.24M
Days to cover1.2d
Short volume56.3%
Squeeze score44 / 100
Next earningsFri, Aug 14, 2026 · pre-mkt (4d)
EPS forecast−$0.09 · 3 est
Last EPS vs est−$0.16 vs −$0.12
Last surprise-33.3% miss
Setup gradeC
Conviction48 / 100
Pattern quality—
Tech rank64.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.88
Support0.8300
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OTLK

All disclosures →
No recent disclosed trades by Congress in OTLK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OTLK · 6 buys · 4 sells

InsiderSideShares
Haddadin Yezan Munther
Director · Common Stock · 2026-06-02
Buy29K
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Dispose8.57M
GMS Ventures & Investments
Director · Warrants (right to buy) · 2026-05-28
Buy8.57M
GMS Ventures & Investments
Director · Warrants (right to buy) · 2026-05-28
Dispose8.57M
GMS Ventures & Investments
Director · Warrants (right to buy) · 2026-05-28
Dispose3.46M
Sukhtian Ghiath M.
Director · Common Stock · 2026-05-28
Buy8.54M
GMS Ventures & Investments
Director · Common Stock · 2026-05-28
Buy8.54M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Buy3.46M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Buy8.57M
Sukhtian Ghiath M.
Director · Warrants (right to buy) · 2026-05-28
Dispose3.46M

SEC filings

EDGAR filings in OTLK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.